Navigation Links
Soligenix Reports Year-End 2012 Financial Results and Highlights Recent Accomplishments
Date:2/26/2013

PRINCETON, N.J., Feb. 26, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today its financial results for the year ended December 31, 2012.

Soligenix's revenues for the year ended December 31, 2012 were $3.1 million as compared to $7.6 million for the prior year. The decrease in revenues was a result of $5.0 million received in 2011 from Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) for rights to orBec® (oral beclomethasone 17,21-dipropionate or BDP) in the European territory. Grant revenue increased by $0.5 million primarily related to increased reimbursable costs from the Company's four active government funded programs most notably our ThermoVax™ thermostability technology grant focused on a novel method of rendering aluminum salt adjuvanted vaccines stable at elevated temperatures. 

Soligenix's net (loss) for December 31, 2012 was $4.2 million, or $(0.37) per share, as compared to $2.4 million, or $(0.22) per share, for the year ended December 31, 2011, representing an increased loss of $1.8 million. This increased loss is primarily related to the receipt of $5.0 million from Sigma-Tau in 2011 for the rights to orBec® in the European territory offset by decreased expenses in research and development related to the conduct of our Phase 3 trial of orBec® in the treatment of acute gastrointestinal Graft versus Host disease (GI GVHD). 

Research and development expenses for the full year 2012 were $2.6 million as compared to $6.3 million for the full year 2011. This significant decrease is primarily attributable to the discontinued Phase 3 trial of orBec® and the payment of approximately $1.0 million in the form of cash and company stock to our orBec® licensor in connection with the Sigma-Tau Agreement.  General and administra
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Soligenix Announces 1 for 20 Reverse-Split of its Common Stock
2. Soligenix Reports Year-End 2011 Financial Results and Highlights Recent Accomplishments
3. Soligenix Announces Collaboration with Infectious Disease Research Institute to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
4. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
5. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
6. Interleukin Genetics Reports Third Quarter 2011 Financial Results
7. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
8. Nile Therapeutics Reports 2011 Third Quarter Financial Results
9. Pharmasset Reports Fiscal Year End 2011 Financial Results
10. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
11. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 ... ancestry tracing for people of African descent, today ... product offering. For people of all races, myDNAmix ... from five distinct populations: Indigenous Americas (Native American), ... India Subcontinent. , Originally launched in ...
(Date:5/23/2013)... St. Louis, Missouri (PRWEB) May 23, 2013 ... design and manufacture of complete thermal systems, recently ... more than 90 years of experience in designing ... most complete selection of products to serve diverse ... lead-time options is featured at the beginning of ...
(Date:5/22/2013)... 22, 2013 Oven Industries announces the ... integrated potentiometers or via a PC through the TTL ... and one half inches square can deliver up to ... switched, low noise solid state relay. Operator safety is ... the communication port and sensor input. Specifications: Input ...
(Date:5/22/2013)... Boston, MA (PRWEB) May 22, 2013 ... to present at last week’s “Data Demonstration Day” on Capitol ... Cambridge Semantics joined EMC, Google, Microsoft and others to showcase ... the proposed Digital Accountability and Transparency Act (DATA Act). , ... Darrell Issa (R-CA) and Sen. Mark ...
Breaking Biology Technology:AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Watlow Introduces Its New Industrial Heater Catalog 2New AC Temperature Controller Announced by Oven Industries 2Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2
... C3i, the leader in technology services for the life ... biopharmaceutical company, will deliver a joint presentation discussing the ... Oracle Clinical/Remote Data Capture (OCRDC) software. The presentation will ... User Group conference (OHSUG) in San Antonio, TX October ...
... Eagles, Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New... -- NEW YORK, October 5, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... the world of pesticides and pest control, and a range ... public health, ensure that this is done safely, maximize the ... new report. In a study published today in the ... from Oregon State University and the European Union outline six ...
Cached Biology Technology:C3i and Bristol-Myers Squibb to Discuss the Effects of Oracle Clinical 4.5.3 Zero Footprint on Support Services at the Oracle Health Sciences User Group Conference 2Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 2Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 3Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 4Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 5Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 6Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 7Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 8Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 9Philadelphia Eagles' Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line 10New approaches needed to gauge safety of nanotech-based pesticides 2New approaches needed to gauge safety of nanotech-based pesticides 3
(Date:5/22/2013)... engineering drastically reduces the time and effort needed ... of biotechnology, scientists are reporting. Published in the ... paves the way for more rapid development of ... other activities. , Keith Shearwin and colleagues explain ... genetic material DNA into a bacterium,s genome is ...
(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, ... order to infect us, this pathogen has developed a ... unnoticed in our cells, thus avoiding these acting against ... biosciences research centre, CIC bioGUNE, in which teams from ... and the National Supercomputation Centre in Barcelona (BSC) have ...
(Date:5/22/2013)... in the biodiversity of pollinating insects and wild plants ... study. , Researchers led by the University of Leeds ... evidence of dramatic reductions in the diversity of ... 1950s and 1980s. , But the picture brightened markedly ... biodiversity losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... chemotherapy drugs kill cancerous tumours in a bid to ... new agents. , Dr Stephen Taylor and Karen Gascoigne at ... taken a new systematic approach to studying anti-mitotic drugs, ... in the UK. This class of drugs, which ...
... Spanish . The journal " Science " ... the results of a detailed research work about the evolution ... The study has been carried out with the participation of ... The results obtained prove that the main concentrations of biodiversity ...
... offer new possibilities for Insurance, ... ROCHESTER, N.Y., Aug. 5 Pictometry International ... libraries whose,proprietary technology is used globally to ... new alliance with First American Proxix,Solutions, a ...
Cached Biology News:How chemo kills tumors: research to reduce side effects 2How chemo kills tumors: research to reduce side effects 3Fossil and molecular evidence reveals the history of major marine biodiversity hotspots 2Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM) 2Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM) 3